new oral glp 1 agonist Trends in the Development of GLP-1 Receptor Agonists

Doctors report that GLP 1 medications, originally approved for obesity and diabetes, are increasingly being used to help women with Polycystic Ovary Syndrome (PCOS) a hormonal disorder often tied to weight gain, Could popular diabetes and weight loss drugs influence blood cancer risk? GLP 1 receptor agonistsdrugs like Ozempic and Wegovy ( Novo Nordisk Foundation ) are widely prescribed for type 2 diabetes and weight loss. In the phase 3 ACHIEVE 1 trial, published in June 2025, the oral small molecule GLP 1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with To begin our 5 week series on GLP 1 medications, we're starting with an important topic: Nutrition and GLP 1s. GLP 1 medications work by: Reducing hunger and appetite Decreasing comfort eating and food How GLP 1 medications are transforming diabetes and weight loss treatment Vital Record